Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.
Twitter handle: @jeffmason1
Johnson & Johnson posted better-than-expected third-quarter earnings, raising its full-year forecast due to growth from new cancer drugs and high-margin treatments picked up in its $30 billion acquisition of Actelion earlier this year.
A U.S. judge on Monday invalidated patents on Allergan Plc's dry-eye medicine Restasis on grounds that the patents cover ideas that are obvious, sending shares of the pharmaceutical company down 3.5 percent.
NEW YORK Shares of U.S. hospital companies and health insurers fell on Friday after President Donald Trump said he would cut off Obamacare subsidies to health insurance companies for low-income patients, a move that could make healthcare less affordable next year for some people.
Allergan Plc said on Thursday it reached a settlement with InnoPharma Inc, one of the four generic drugmakers challenging the patents for its dry eye medication Restasis in federal court.
NEW YORK Democratic U.S. Senator Claire McCaskill on Thursday said she drafted a bill stating that tribal sovereign immunity cannot be used to block U.S. Patent and Trademark Office review of a patent.
NEW YORK, Oct 5 Democratic U.S. Senator Claire McCaskill on Thursday said she drafted a bill stating that tribal sovereign immunity cannot be used to block U.S. Patent and Trademark Office review of a patent.
Mylan NV's long-awaited U.S. approval for its generic version of rival Teva's blockbuster multiple sclerosis treatment Copaxone drove Mylan's shares up around 18 percent on Wednesday while Teva shares plunged.
NEW YORK Allergan Plc Chief Executive Brent Saunders on Tuesday defended his company's decision to transfer drug patents to a Native American tribe as a proper way to shield them from a flawed patent review process, in a response to congressional criticism.
NEW YORK A U.S. House of Representatives committee launched a probe into drugmaker Allergan Plc's deal to transfer some of its patents to a Native American tribe to shield them from review.
NEW YORK, Sept 29 Eli Lilly and Co named a new chief financial officer and replaced the head of its research and development arm, among other changes to its top management on Friday, weeks after the drugmaker announced layoffs to cut costs.
- Gold: PRECIOUS-Gold edges up, but stuck in tight range
- Oil Report: Kurds report Iraq attack south of oil export pipeline, Iraqi military deny
- British Pound Report: Sterling bounces back, boosted by progress in Brexit talks
- US Dollar Report: FOREX-Dollar inches lower as attention turns to Fed leadership